OncoSenX

About:

OncoSenX is a developer of transient gene therapies designed for solid tumors.

Website: https://www.oncosenx.com/

Top Investors: Canadian Institutes of Health Research, SENS Foundation, Helios Capital, Avant Global, Althea Ventures

Description:

OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more precise intervention for this complex and devastating disease.